1. Home
  2. SUNS vs MDXH Comparison

SUNS vs MDXH Comparison

Compare SUNS & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUNS
  • MDXH
  • Stock Information
  • Founded
  • SUNS 2023
  • MDXH 2003
  • Country
  • SUNS United States
  • MDXH Belgium
  • Employees
  • SUNS N/A
  • MDXH N/A
  • Industry
  • SUNS Real Estate Investment Trusts
  • MDXH
  • Sector
  • SUNS Real Estate
  • MDXH
  • Exchange
  • SUNS Nasdaq
  • MDXH Nasdaq
  • Market Cap
  • SUNS 148.0M
  • MDXH 141.1M
  • IPO Year
  • SUNS N/A
  • MDXH 2021
  • Fundamental
  • Price
  • SUNS $9.94
  • MDXH $4.52
  • Analyst Decision
  • SUNS Strong Buy
  • MDXH Buy
  • Analyst Count
  • SUNS 3
  • MDXH 1
  • Target Price
  • SUNS $13.58
  • MDXH $6.00
  • AVG Volume (30 Days)
  • SUNS 73.0K
  • MDXH 189.5K
  • Earning Date
  • SUNS 11-13-2025
  • MDXH 11-05-2025
  • Dividend Yield
  • SUNS 12.06%
  • MDXH N/A
  • EPS Growth
  • SUNS N/A
  • MDXH N/A
  • EPS
  • SUNS 1.04
  • MDXH N/A
  • Revenue
  • SUNS $16,359,932.00
  • MDXH $98,953,000.00
  • Revenue This Year
  • SUNS $183.25
  • MDXH $24.40
  • Revenue Next Year
  • SUNS $62.46
  • MDXH $22.29
  • P/E Ratio
  • SUNS $9.54
  • MDXH N/A
  • Revenue Growth
  • SUNS 1342.10
  • MDXH 22.56
  • 52 Week Low
  • SUNS $7.80
  • MDXH $1.35
  • 52 Week High
  • SUNS $15.74
  • MDXH $4.94
  • Technical
  • Relative Strength Index (RSI)
  • SUNS 34.63
  • MDXH 69.80
  • Support Level
  • SUNS $9.77
  • MDXH $4.60
  • Resistance Level
  • SUNS $10.29
  • MDXH $4.94
  • Average True Range (ATR)
  • SUNS 0.31
  • MDXH 0.27
  • MACD
  • SUNS -0.14
  • MDXH -0.02
  • Stochastic Oscillator
  • SUNS 6.20
  • MDXH 75.33

About SUNS Sunrise Realty Trust Inc. Common Stock

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: